593 Efficacy of invariant natural killer T cell infusion plus transarterial embolization vs transarterial embolization alone for hepatocellular carcinoma patients: a phase 2 randomized clinical trial

Abstract

BackgroundHepatocellular carcinoma remains a leading cause of mortality worldwide, accounting for over three quarter of a million deaths annually.1 While transarterial chemoembolization (TACE) therapy is the current first-line intervention for...